$1.10
0.021.85%
Last update: Oct 7, 9:28 AM
$1.10
0.021.85%
Tvardi Therapeutics Inc
TVRDNASDAQ
Tvardi Therapeutics (TVRD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.64 | $-0.70 | $-0.56 | $-0.91 |
| Actual | $-0.69 | $-0.73 | $-0.78 | $-0.59 |
| Surprise | -7.81% | -4.29% | -39.3% | +35.2% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.56 | $-0.46 | $-0.60 | $-0.64 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.69 | $-0.64 | -7.81 % |
| Q1 | May 8, 2026 | $-0.73 | $-0.70 | -4.29 % |
| Q4 | Mar 31, 2026 | $-0.78 | $-0.56 | -39.3 % |
| Q3 | Nov 13, 2025 | $-0.59 | $-0.91 | 35.2 % |
